PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysis
There are few tissue-based biomarkers that can accurately predict prostate cancer (PCa) progression and aggressiveness. We sought to evaluate the clinical utility of prostate and breast overexpressed 1 (PBOV1) as a potential PCa biomarker.Patient tumor ...